Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm …
K Aokage, K Suzuki, H Saji, M Wakabayashi… - The Lancet …, 2023 - thelancet.com
Background Although segmentectomy is a widely used surgical procedure, lobectomy is the
standard procedure for resectable non-small-cell lung cancer (NSCLC). This study aimed to …
standard procedure for resectable non-small-cell lung cancer (NSCLC). This study aimed to …
Radiomics for survival risk stratification of clinical and pathologic stage IA pure-solid non–small cell lung cancer
Background Radiomics-based biomarkers enable the prognostication of resected non–small
cell lung cancer (NSCLC), but their effectiveness in clinical stage and pathologic stage IA …
cell lung cancer (NSCLC), but their effectiveness in clinical stage and pathologic stage IA …
[HTML][HTML] Management of ground-glass nodules: when and how to operate?
YT Kim - Cancers, 2022 - mdpi.com
Simple Summary An increasing number of lung cancer screening programs have detected
the frequent occurrence of small pulmonary ground-glass nodules (GGNs). If GGN is an …
the frequent occurrence of small pulmonary ground-glass nodules (GGNs). If GGN is an …
[HTML][HTML] Mechanism and clinical application of thymosin in the treatment of lung cancer
Y Liu, J Lu - Frontiers in Immunology, 2023 - frontiersin.org
Cancer is one of the leading causes of death worldwide. The burden of cancer on public
health is becoming more widely acknowledged. Lung cancer has one of the highest …
health is becoming more widely acknowledged. Lung cancer has one of the highest …
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L) …
A Hattori, K Suzuki, K Takamochi… - The Lancet …, 2024 - thelancet.com
Background Although segmentectomy was better than lobectomy in terms of overall survival
for patients with non-small-cell lung cancer (NSCLC) with a pure-solid tumour appearance …
for patients with non-small-cell lung cancer (NSCLC) with a pure-solid tumour appearance …
[HTML][HTML] Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non–small cell lung cancer
Y Watanabe, A Hattori, S Nojiri, T Matsunaga… - The Journal of Thoracic …, 2022 - Elsevier
Objective Non–small cell lung cancers with a ground-glass opacity component have better
prognosis than those with solid nodules of equivalent consolidation size. However, the …
prognosis than those with solid nodules of equivalent consolidation size. However, the …
Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I non-small-cell lung cancer
T Akamine, M Yotsukura, Y Yoshida… - European Journal of …, 2023 - academic.oup.com
OBJECTIVES With recent improvements in surgical techniques for segmentectomy, we
hypothesized that segmentectomy is feasible and more effective than wedge resection for …
hypothesized that segmentectomy is feasible and more effective than wedge resection for …
[HTML][HTML] Comparison of lobectomy and sublobar resection for stage IA elderly NSCLC patients (≥ 70 Years): A population-based propensity score matching's study
B Zhang, R Liu, D Ren, X Li, Y Wang, H Huo… - Frontiers in …, 2021 - frontiersin.org
Background To investigate the differences in survival between lobectomy and sub-lobar
resection for elderly stage I non-small-cell lung cancer (NSCLC) patients using the …
resection for elderly stage I non-small-cell lung cancer (NSCLC) patients using the …
Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer
A Kamigaichi, T Mimae, N Tsubokawa… - Interdisciplinary …, 2023 - academic.oup.com
OBJECTIVES This study aimed to compare cancer control after segmentectomy and
lobectomy in patients with radiologically pure-solid clinical stage IA3 non-small-cell lung …
lobectomy in patients with radiologically pure-solid clinical stage IA3 non-small-cell lung …
Real‐world comprehensive diagnosis and “Surgery+ X” treatment strategy of early‐stage synchronous multiple primary lung cancer
D Zhou, T Yao, X Huang, F Wu, Y Jiang… - Cancer …, 2023 - Wiley Online Library
Background Diagnosing and treating synchronous multiple primary lung cancers (sMPLC)
are complex and challenging. This study aimed to report real‐world data on the …
are complex and challenging. This study aimed to report real‐world data on the …